Learning to warm the fingers voluntarily reduces vasospastic attacks: six randomised trials support this classic thermal biofeedback application. Results are better where patients actually learn to raise their temperature.
AAPB4EfficaciousNeuroLogic4Efficacioussame vs AAPB
Level 4 maintained. Six randomised trials underpin the rating. The positive evidence comes mainly from Freedman's group: Freedman & Ianni 1983 (n = 32 — finger temperature feedback raised hand temperature with and without feedback and reduced vasospastic attacks by 66.8 % at 1 year, temperature feedback with cold challenge by 92.5 %, both more than frontal EMG feedback or autogenic training) and Freedman 1988 (n = 34 — attacks fell 81.3 % in year 1 and 80.5 % at 2 years after temperature feedback, with no significant change after autogenic training). Sporbeck 2012 is an independent replication in Raynaud's phenomenon secondary to systemic sclerosis (n = 28, three arms): temperature feedback reduced the scleroderma visual analogue score against a waitlist at 4 weeks, whereas deep oscillation did not. The three other randomised trials (Surwit 1978, n = 30; Jacobson 1979, n = 12; Keefe 1980, n = 21) added no advantage to autogenic training or relaxation, and the two largest trials — Guglielmi 1982 (n = 36, double-blind) and the Raynaud's Treatment Study 2000 (n = 313) — were null; in these, fewer than 50 % and 35 % of patients had learned voluntary vasodilation.
In short
Clinical reading
AAPB Level 4, maintained by NeuroLogic on six RCTs, including two positive trials from Freedman's group (1983, 1988) with two- and three-year follow-up and an independent replication in systemic sclerosis (Sporbeck 2012). The two largest studies, both null, did not train patients to a mastery criterion and did not assess self-regulation without feedback.
Protocols
Digital temperature biofeedback targeting voluntary vasodilation (for example 34 °C for 15 minutes), cold-stress conditions built into training, a no-feedback session for transfer, active coaching and daily home practice — the Karavidas 2006 recommendations endorsed by AAPB.
Limits
In the two largest studies, rigid protocols and deficient coaching meant fewer than 50 % and 35 % of participants achieved voluntary vasodilation, likely diluting results. No 2022-2026 study. Nothing published in children or adolescents.
Study base
Six RCTs, one quasi-experiment and a detailed critical review of the literature (Karavidas 2006). 2022-2026 base: no publication indexed in the archive.
Brendan's perspective
Level 4 maintained, and the most interesting reading here is not in the positive trials but in the null ones. The favourable results come mainly from Freedman's own group (1983, 1988), with one genuinely independent replication, Sporbeck 2012, against a waitlist in systemic sclerosis. The two largest trials, Guglielmi 1982 and the Raynaud's Treatment Study 2000 (n = 313), were null — and in those trials fewer than 50 % and fewer than 35 % of participants had learned voluntary vasodilation. That is not a null against the method; it is a null against how the method was delivered: fixed dose, rigid protocol, coaching reduced to encouragement, no learning criterion. The Karavidas 2006 recommendations correct precisely that: train to a temperature criterion, build cold stress into training, run a no-feedback session for transfer. I do not see much Raynaud's. And even done well, this is attack frequency, not disease modification.
Sporbeck et al. (2012) Effect of biofeedback and deep oscillation on Raynaud's phenomenon secondary to systemic sclerosis: results of a controlled prospective randomized clinical trial doi:10.1007/s00296-011-1882-2
Raynaud's Treatment Study Investigators (2000) Comparison of sustained-release nifedipine and temperature biofeedback for treatment of primary Raynaud phenomenon: results from a randomized clinical trial with 1-year follow-up doi:10.1001/archinte.160.8.1101
